MA
64
7
PGR
65
2
DG
6
2
WU
32
2
HON
67
2
CRM
67
2
PRGO
39
3
MCD
52
2
SNA
68
-2
NKE
36
6
WDC
47
4
LYB
39
2
STZ
54
-3
CPB
30
6
ADBE
49
3
NEE
50
-5
FE
50
-2
GOOGL
40
-5
HRB
57
5
PG
56
5
MA
64
7
PGR
65
2
DG
6
2
WU
32
2
HON
67
2
CRM
67
2
PRGO
39
3
MCD
52
2
SNA
68
-2
NKE
36
6
WDC
47
4
LYB
39
2
STZ
54
-3
CPB
30
6
ADBE
49
3
NEE
50
-5
FE
50
-2
GOOGL
40
-5
HRB
57
5
PG
56
5
Financhill
Back

Biomarin Pharmaceutical Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
61

BMRN
Biomarin Pharmaceutical

Last Price:
64.25
Seasonality Move:
12.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Biomarin Pharmaceutical Price Quote

$64.25
-0.01 (1.26%)
(Updated: November 23, 2024 at 5:27 AM ET)

Biomarin Pharmaceutical Key Stats

Buy
61
Biomarin Pharmaceutical (BMRN) is a Buy
Day range:
$63.78 - $64.46
52-week range:
$61.15 - $99.56
Dividend yield:
0%
P/E ratio:
73.86
P/S ratio:
4.58
P/B ratio:
2.26%
Volume:
1.3M
Avg. volume:
1.5M
1-year change:
-27.32%
Market cap:
$12.2B
Revenue:
$2.4B
EPS:
$1.67

How Much Does Biomarin Pharmaceutical Make?

Is Biomarin Pharmaceutical Growing As A Company?

Biomarin Pharmaceutical Stock Price Performance

What Is Biomarin Pharmaceutical 52-Week High & Low?

Biomarin Pharmaceutical Price To Free Cash Flow

Is It Risky To Buy Biomarin Pharmaceutical?

Is Biomarin Pharmaceutical Cash Flow Positive?

  • What Is BMRN Cash Flow From Operations?
    Cash flow from operations (TTM) is $414.7M
  • What Is Biomarin Pharmaceutical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$518.5M
  • What Is Biomarin Pharmaceutical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$4.9M

Biomarin Pharmaceutical Return On Invested Capital

  • Is Management Doing A Good Job?
    BMRN return on invested capital is 5.27%
  • What Is Biomarin Pharmaceutical Return On Assets?
    ROA measures how assets are converting to revenues and is 4.69%
  • What Is BMRN Return On Equity?
    ROE is a measure of profitability and is 6.29%

Biomarin Pharmaceutical Earnings Date & Stock Price

Biomarin Pharmaceutical Competitors

Biomarin Pharmaceutical Dividend Yield

Biomarin Pharmaceutical Analyst Estimates

YoY Growth Past Surprise
EPS: 161.91% 14.73%
Revenue: 28.28% 6.03%

Analyst Recommendations

Buy Recommendations: 14
Hold Recommendations: 5
Sell Recommendations: 0
Price Target: 98.39
Upside from Last Price: 53.11%

Major Shareholders

  • How many BMRN shares are owned by institutional investors?
    314.2M BMRN shares are owned by institutional investors
  • How many BMRN shares are owned by insiders?
    2.5M BMRN shares are owned by insiders